The launch demonstrates the company’s continued commitment to offering on-label, approved products specifically for myopia control management to patients and eye care practitioners worldwide.
Menicon Co., Ltd. is pleased to announce the launch of Menicon Bloom™, a holistic treatment plan for myopia control in seven additional markets worldwide together with a powerful and impressive marketing campaign titled “See Their Imagination Bloom”.
Myopia, also known as near- or short-sightedness, is a common refractive error and one of the major causes of vision impairment worldwide. It affects approximately 30% of the world’s population and its prevalence has been forecast to affect about 50% of the world’s population by 2050. The prevalence of myopia in young adolescents has been increasing in recent decades to about 30% in industrialized societies of the West and epidemic levels of over 90% in some parts of Far East Asia. Globally, it is recognized as a significant public health concern associated with increased ocular-related morbidity and considerable healthcare costs.
Concerned with the growing incidence of myopia and its health consequences worldwide, Menicon Co., Ltd. has developed Menicon Bloom™, a comprehensive treatment plan for childhood myopia that features two contact lenses that are CE-approved specifically for myopia control: Menicon Bloom Night™, a specially designed orthokeratology contact lens, and Menicon Bloom Day™, an extended depth of focus soft daily disposable contact lens. Combined with specially formulated Menicon Bloom™ lens care solutions, state-of-the-art fitting software and an innovative Menicon Bloom™ app, this holistic treatment plan helps slow down the progression of childhood myopia while providing all the tools for a successful myopia journey.
The launch is being enhanced with an exciting marketing campaign titled “See Their Imagination Bloom” to raise awareness of childhood myopia and its possible treatment options. With a rich and vibrant visual world of imagination, the campaign aims to make it reassuringly easy for parents and eye care professionals around the world to incorporate the Menicon Bloom™ treatment plan into children’s daily routines.
Please contact your local Menicon representative to get more information on the availability of Menicon Bloom™ in your country.
About Menicon Co., Ltd.
Menicon Co., Ltd. (7780: Tokyo), founded by Mr. Kyoichi Tanaka in 1951, is Japan’s first and largest contact lens manufacturer, and is represented in over 80 countries. Menicon is a manufacturer dedicated to all areas of soft and gas-permeable contact lens-related businesses including manufacturing, sales, export and import of contact lenses and other medical goods; manufacturing and sales of medical instruments; sales of medical supplies; and research and development of intraocular lenses. For more information, please visit: https://www.menicon.com/